# Safety and Efficacy Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder

> **NCT01179516** · PHASE3 · COMPLETED · sponsor: **Takeda** · enrollment: 469 (actual)

## Conditions studied

- Depressive Disorder, Major

## Interventions

- **DRUG:** Vortioxetine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01179516
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2012-05
- **Final completion:** 2012-06
- **Target enrollment:** 469 (ACTUAL)
- **Last updated:** 2013-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01179516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01179516, "Safety and Efficacy Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01179516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*